Unichem Labs - About the company
Unichem Labs is an acquired company based in Mumbai (India), founded in 1944 by Prakash A Mody and Shri Amrut Mody. It operates as a Manufacturer of branded formulations, APIs, and biosimilars. Unichem Labs has raised an undisclosed amount in funding. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Biological E.
Company Details
Unichem Labs is a manufacturer of active pharmaceutical ingredients and formulations. It focuses on gastroenterology, cardiology, diabetology, psychiatry, neurology, antibacterials, anti-infectives and pain management among others. It also has established a biotech facility to develop and commercialize biosimilar products using recombinant DNA technologies.
- Website
- unichemlabs.com
- Social
- Email ID
- *****@unichemlabs.com
- Phone Number
- +91 **********
- Registered Address
- 47, Kandivli Industrial Estate, Kandivali West, Mumbai, Kandivali West, Maharashtra, India, 400067
Key Metrics
Founded Year
1944
Location
Mumbai, India
Stage
Acquired
Latest Funding Round
Investors
Ranked
14th among 198 active competitors
Employee Count
2,577 as on Jan 31, 2025
Investment & Acquisitions
Exit Details
Acquired by Ipca Laboratories (Jun 01, 2023)
Legal entities associated with Unichem Labs
Unichem Labs is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
UNICHEM LABORATORIES LIMITED CIN: L99999MH1962PLC012451 , India, Active | Aug 22, 1962 | ₹1,000+ Cr (As on Mar 31, 2025) | 2577 (As on Jan 31, 2025) |
Unichem Labs's acquisition details
Unichem Labs got acquired by Ipca Laboratories on Jun 01, 2023.
Click here to take a look at Unichem Labs's acquisition in detail
Sign up to download Unichem Labs' company profile
Unichem Labs's funding and investors
Unichem Labs has raised funding over 2 rounds. Its latest funding round was a Post IPO round on Apr 24, 2023 for $*****. 1 investor participated in its latest round. Unichem Labs has 3 institutional investors.
Here is the list of recent funding rounds of Unichem Labs:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 24, 2023 | 7136050 | Post IPO | 1992755 | 2294013 | 9278765 | 4147184 |
Access funding benchmarks and valuations. Sign up today!View details of Unichem Labs's funding rounds and investors
Unichem Labs' founders and board of directors
Founder? Claim ProfileThe founders of Unichem Labs are Prakash A Mody and Shri Amrut Mody. Prakash A Mody is the CEO of Unichem Labs.
Here are the details of Unichem Labs' key team members:
- Prakash A Mody: Co-CEO & Owner of Unichem Labs. They are also an angel investor in 1 startup.Contact Info: 1 email address
- Shri Amrut Mody: Former Founder of Unichem Labs. Contact Info: 1 email address
View details of Unichem Labs's Founder profiles and Board Members
Unichem Labs' employee count trend
Unichem Labs has 2,577 employees as of Jan 25. The total employee count is 5.0% more than what it was in Jan 24. Here is Unichem Labs's employee count trend over the years:
Uncover Unichem Labs' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Unichem Labs's Competitors and alternates
Top competitors of Unichem Labs include Bayer, Wockhardt and Biological E. Here is the list of Top 10 competitors of Unichem Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
3rd |  Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
4th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
5th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
6th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
7th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
8th | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | - | 67/100 | ||
9th |  Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th |  Dr. Reddy's Laboratories 1984, Hyderabad (India), Public | Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health | - | 65/100 | |
14th | Unichem Labs 1944, Mumbai (India), Acquired | Manufacturer of branded formulations, APIs, and biosimilars | - | 64/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Unichem Labs's competitors? Click here to see the top ones
Unichem Labs's Investments and acquisitions
Unichem Labs has a total of 1 investment in Optimus. Unichem Labs has not made any acquisitions as of now.Reports related to Unichem Labs
Here is the latest report on Unichem Labs's geography:
News related to Unichem Labs
Filter this listMedia has covered Unichem Labs for 1 event in last 1 year, It was about company updates.
•
•
Unichem Acquires 51% Stake in Hi-end for ₩6.1 Billion, Entering Entertainment BusinessBloter•Sep 08, 2025•Unichem Labs
•
Guttify has raised USD 360K in an extended Seed funding round led by Prajay Advisors, and othersEnablers•May 05, 2025•Guttify, Prajay Advisors, Unichem Labs
•
Unichem board to consider integrating US formulation biz under single entityIndiatimes•Sep 23, 2024•Unichem Labs
•
Unichem Laboratories Q1 results : profit at ₹9.26Cr, Revenue increased by 5.49% YoYMint•Aug 09, 2024•Unichem Labs
•
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem LaboratoriesGlobeNewswire•Jun 05, 2024•Axsome Therapeutics, Unichem Labs
•
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem LaboratoriesFinancial Post•Jun 05, 2024•Axsome Therapeutics, Unichem Labs
•
•
Unichem Laboratories Q3 FY24 results: profit at ₹83.99Cr, Revenue increased by 43.6% YoYMint•Feb 07, 2024•Unichem Labs
•
Unichem Laboratories hit 52-week high on USFDA nod for hypertension drugMoneycontrol•Jan 11, 2024•Unichem Labs
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Unichem Labs
Explore our recently published companies
- Linz Pharmaceuticals - Karachi based, 2010 founded, Unfunded company
- Asamedic - Unfunded company
- JSW Group - Mumbai based, 1982 founded, Public company
- UIN - Buenos Aires based, 2025 founded, Seed company
- Green Lighthouse Developpement - Martillac based, 2018 founded, Unfunded company
- Apollosales.co - 2026 founded, Unfunded company
